Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: p90RSK pathway inhibition synergizes with cisplatin in TMEM16A overexpressing head and neck cancer

Fig. 1

Cisplatin EC50 values for HNSCC cell lines in vitro. Cell proliferation assay at 72 h to determine EC50 values for cisplatin in the (A) indicated cell lines and (C and D) cisplatin resistant HN30-R8 and HN31-P10. Representative graphs from one experiment are shown. (B and E) Table indicating average EC50 value. Statistical significance was calculated using Student’s t-test. *p < 0.05

Back to article page